Delivery Order SPE2DB20D2001-SPE2DB25FPNMB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,071.28 to AmerisourceBergen Drug Corp for the supply of Estrogen-Methyltestosterone tablets (100 count) on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1,454.40 to AmerisourceBergen Drug Corp for Estrogen-Methyltestosterone tablets (100 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,584.51 to AmerisourceBergen Drug Corp for the supply of Estrogen-Methyltestosterone tablets (100 count) on April 24, 2025, with completion scheduled for April 25, 2025. This non-set-aside contract represents a firm fixed price delivery order executed under competitive procurement procedures. The award leverages AmerisourceBergen's extensive pharmaceutical distribution capabilities and established relationship with the Defense...
- The Defense Logistics Agency awarded a $1,049.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Estrogen-Methyltestosterone tablets (100 count) with a completion date of September 9, 2025. This competitive award, with no set-aside designation, is being fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Estrogen-Methyltestosterone tablets (100 count) with a ceiling value of $3,170.48. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 18, 2025. This delivery...
- The Defense Logistics Agency awarded a $1,940.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for estrogen-methyltestosterone tablets (100-count) on September 25, 2025, with completion scheduled for September 26, 2025. This non-set-aside contract was competitively awarded to the major pharmaceutical distributor and reflects routine medical supply procurement for military healthcare needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $1,161.18 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Estrogen-Methyltestosterone tablets (100 count). This firm fixed price contract, with an ultimate completion date of August 7, 2025, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the...
- The Defense Logistics Agency awarded a delivery order valued at $1,317.41 to AmerisourceBergen Drug Corp for Estrogen-Methyltestosterone tablets (100-count) with a firm fixed price structure. This non-set-aside contract was awarded on August 19, 2025, with an ultimate completion date of August 20, 2025. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,230 to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 100 tablets of Estrogen-Methyltestos F.S. tablets to be delivered to a location in Conshohocken, Pennsylvania by July 14, 2023. No additional details were provided regarding the original solicitation or whether this delivery order is associated with any broader indefinite delivery/indefinite quantity...
- This federal contract award, valued at $1,195.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of "ESTROGEN-METHYLTESTOS F.S. TAB 100S", a pharmaceutical product. The contract has an ultimate completion date of December 3, 2024 and is a Firm Fixed Price agreement. There is no set-aside designation on this award. Amerisourcebergen...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPNMBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,326.72 to AmerisourceBergen Drug Corp for the supply of Estrogen-Methyltestosterone tablets (100 count) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive award utilizes firm fixed pricing with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. The contractor's contract portfolio demonstrates extensive experience fulfilling federal pharmaceutical requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and vaccines for customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/18/25 |